Search Results

Displaying Results 126-150 of 291 "'INT'"

Apr 21, 2026, 10:39 ET La gama mejorada de criptomonedas de Axi ofrece una adopción de cartera del 46 % entre los clientes

https://www.axi.com/int/blog/education/cryptocurrencies/spot-trading-cryptocurrencyAcerca de AxiAxi es una marca mundial de operaciones en línea de FX y CFD, que atiende

More news about: AxiTrader


Apr 21, 2026, 06:00 ET Axi's Enhanced Crypto Range Delivers 46% Portfolio Adoption Among Clients

https://www.axi.com/int/blog/education/cryptocurrencies/spot-trading-cryptocurrencyAbout AxiAxi is a global online FX and CFD trading brand, serving thousands of customers

More news about: AxiTrader


Apr 21, 2026, 06:00 ET Axi's Enhanced Crypto Range Delivers 46% Portfolio Adoption Among Clients

https://www.axi.com/int/blog/education/cryptocurrencies/spot-trading-cryptocurrencyAbout AxiAxi is a global online FX and CFD trading brand, serving thousands

More news about: AxiTrader


Apr 20, 2026, 07:50 ET Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease

M. Okubo, O. Valzer, R. Kornowski, H. Matsuo. Angiogram based fractional flow reserve in patients with dual/triple vessel coronary artery disease. Int J Cardiol. 2019 May 15:283:17-22. doi: 10.1016/j.ijcard.2019.01.072. Epub 2019 Jan 27.3. Witberg G, De Bruyne B, Fearon WF, Achenbach S, Engstrom

More news about: Medtronic plc


Apr 16, 2026, 09:30 ET Why Smart Money is Securing Pivotal Gold Reserves Now

https://capital.com/en-int/market-updates/gold-price-forecast-03-03-2026 

More news about: USA News Group


Apr 15, 2026, 10:30 ET Artilux Announces Inception™: A Hybrid Optoelectronic Architecture for the Next-Generation AI Computing

at the forefront of the AI computing industry. Extending beyond the published research, this processing core is designed to deliver over 12,000 TOPS (INT8) with approximately 50 mW/mm² power density using a standard GHz clock rate. These figures of merit include system components such as drivers, DACs,

More news about: Artilux


Apr 15, 2026, 09:15 ET Intensity Therapeutics Recognized with Pinnacle Award for Excellence in Healthcare Innovation

2026 Pinnacle Awards for Healthcare for its intratumoral injection platform and lead drug candidate INT230-6.

More news about: Intensity Therapeutics Inc.


Apr 14, 2026, 12:59 ET Bridge Defense Acquires Syntelligent Analytic Solutions to Expand Intelligence and Analytics Capabilities

acquisition expands Bridge Defense's capabilities across the intelligence lifecycle, combining Syntelligent's expertise in all-source analysis, multi-INT operations, and geospatial and cyber analytics with Bridge Defense's strengths in software development, infrastructure, and deployable systems. Together,

More news about: Bridge Defense


Apr 09, 2026, 08:00 ET Eisai to Present the Latest Data on Real-World Treatment with Lecanemab and Supporting a Standardized Framework for Treating Early Alzheimer's Disease at the 78th American Academy of Neurology's Annual Meeting

doi:10.1038/s41467-021-23507-z.Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706.Eisai Co., Ltd. E2086, A Selective Orexin Receptor-2

More news about: Eisai Inc.


Apr 08, 2026, 08:03 ET Supira Medical Anuncia Aprovação da FDA para o Estudo Pivotal SUPPORT II, Avanços em Choque Cardiogênico e Nomeação de D. Keith Grossman para o Conselho de Administração

O SUPPORT II (SUpira System in Patients Undergoing High-Risk Percutaneous C OronaRy InT ervention (HRPCI)) é um estudo prospectivo, randomizado e controlado projetado para avaliar a segurança e a eficácia do pVAD de próxima geração

More news about: Supira Medical, Inc.


Apr 08, 2026, 08:03 ET Supira Medical anuncia la aprobación de la FDA para el ensayo pivotal SUPPORT II, los avances en el shock cardiogénico y el nombramiento de D. Keith Grossman como miembro de la junta directiva

SUPPORT II (SUpira System in Patients Undergoing High-Risk P ercutaneousCOronaRe InT ervention (HRPCI)) es un estudio prospectivo, aleatorizado y controlado diseñado para evaluar la seguridad y eficacia del pVAD de próxima generación

More news about: Supira Medical, Inc.


Apr 06, 2026, 09:00 ET AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE

Ponto KA, et al. Quality of life and occupational disability in endocrine orbitopathy. Dtsch Arztebl Int. 2009;106(17):283-289.5

More news about: Amgen


Apr 06, 2026, 03:25 ET CS Analytical to Exhibit at Interphex 2026 - Highlighting Expanded Service Offering

https://interphex26.nvytes.co/interphexinvite2026/INT26CIP106.html

More news about: CS Analytical


Apr 02, 2026, 13:25 ET Funded, Permitted, and Building: The Gold Developers That Didn't Wait

https://capital.com/en-int/market-updates/gold-price-forecast-03-03-2026

More news about: USA News Group


Apr 02, 2026, 11:00 ET GECU Announces New $300 Checking Account Bonus

Percentage Yield (APY) of 0.10% is accurate as of February 18, 2026, and may change after the account is opened. Bonus will be reported on IRS Form 1099-INT (or Form 1042-S, if applicable).2Must have a GECU share account to open a checking account. Open a GECU share account with a one-time

More news about: GECU


Apr 01, 2026, 07:06 ET GFT Technologies Positioned as a Leader in the SPARK Matrix™: Insurance Digital Transformation Services, 2026 by QKS Group

www.gft.com www.gft.com/int/en/blogwww.linkedin.com/company/gft-technologies Media

More news about: QKS Group


Mar 27, 2026, 16:12 ET Intensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update

December 31, 2025, cash and cash equivalents totaled $11.9 million.About INT230-6INT230-6, Intensity's lead proprietary investigational product candidate, is designed for direct intratumoral injection. INT230-6 was discovered using Intensity's proprietary DfuseRx℠ technology platform.

More news about: Intensity Therapeutics Inc.


Mar 26, 2026, 19:12 ET Axi 推出由 Kathy Lien 主持的 Podcast 節目《The Strategy Room》

[email protected]有關 Axi Select 計劃的所有詳情,請瀏覽:https://www.axi.com/int/funded-trader-programAxi Select 計劃只適用於 AxiTrader LLC 的客戶。 差價合約 (CFD) 涉及高風險,投資可能造成損失。 此內容或未能在您所在的地區瀏覽。

More news about: AxiTrader


Mar 26, 2026, 19:08 ET Axi lança podcast "The Strategy Room" apresentando por Kathy Lien

detalhes do programa Axi Select, acesse: https://www.axi.com/int/funded-trader-programO programa Axi Select está disponível apenas para clientes da AxiTrader LLC. Os CFDs apresentam um alto risco de perda de

More news about: AxiTrader


Mar 26, 2026, 19:06 ET Axi presenta el podcast "The Strategy Room" presentado por Kathy Lien

sobre el programa Axi Select, visite: https://www.axi.com/int/funded-trader-programEl programa Axi Select solo está disponible para clientes de AxiTrader LLC. Los CFD conllevan un gran riesgo de pérdida

More news about: AxiTrader


Mar 26, 2026, 12:30 ET 액시, 캐시 리엔 진행 '더 스트래티지 룸' 팟캐스트 출시

[email protected]액시 셀렉트 프로그램에 대한 자세한 내용은 https://www.axi.com/int/funded-trader-program에서 확인할 수 있다.액시 셀렉트 프로그램은 액시트레이더(AxiTrader LLC)의 고객에게만 제공된다. CFD 거래는 높은 투자 손실 위험을 수반한다. 본 콘텐츠는 일부 지역에서는 제공되지 않을 수 있다. 자세한

More news about: AxiTrader


Mar 25, 2026, 18:31 ET Axi startet „The Strategy Room"-Podcast mit Host Kathy Lien

das Axi Select Programm finden Sie auf: https://www.axi.com/int/funded-trader-programDas Axi Select-Programm ist nur für Kunden der AxiTrader LLC verfügbar. CFDs bergen ein hohes Verlustrisiko für Anlegerinnen

More news about: AxiTrader


Mar 25, 2026, 10:53 ET Axi lance le podcast « The Strategy Room » animé par Kathy Lien

programme Axi Select, visitez le site : https://www.axi.com/int/funded-trader-programLe programme Axi Select est uniquement disponible pour les clients d'AxiTrader LLC. Les CFD comportent un risque élevé de

More news about: AxiTrader


Mar 25, 2026, 09:31 ET Axi、「The Strategy Room」ポッドキャストを開始、キャシー・リーン氏がホストを担当

[email protected] Selectプログラムの詳細については、以下をご覧ください:https://www.axi.com/int/funded-trader-programAxi Selectプログラムは、AxiTrader LLCの顧客のみが利用可能です。CFD(差金決済取引)は高い損失リスクを伴います。本コンテンツは、お住まいの地域ではご利用いただけない場合があります。詳細については、当社の利用規約をご参照ください。通常の取引手数料および最低入金額が適用されます。ロゴ

More news about: AxiTrader


Mar 25, 2026, 09:23 ET Axi lanza el podcast "The Strategy Room" presentado por Kathy Lien

detalles del programa Axi Select, visite: https://www.axi.com/int/funded-trader-programEl programa Axi Select sólo está disponible para clientes de AxiTrader LLC. Los CFD conllevan un alto riesgo de pérdida

More news about: AxiTrader


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.